The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
Cryopreservation preserves hematopoietic progenitor cells (HPC) for future use, but the freezing and thawing processes can impact viability. To ensure sufficient viable cells for downstream applications, post-thaw viability testing is essential. This session focuses on standardizing post-thaw viability testing methods, including thawing procedures and viability testing, with an emphasis on CAP proficiency testing and staff training.
Learning Objectives:
Explain the importance of post-thaw viability testing and the benefits of standardization in maintaining the quality of cryopreserved cell products.
Identify optimal thawing conditions for specific cell types and implement standard thawing procedures to ensure the highest post-thaw viability.
Select appropriate viability testing methods for specific cell types and applications, and participate in CAP proficiency testing programs to evaluate and benchmark laboratory performance, ultimately improving the quality control of cryopreserved cell products.
Speaker(s):
Kevin
Land,
MD, CABP(H),
Vice President Clinical Services,
Vitalant
Moderator(s):
Wanxing
Cui,
MD, PhD, CABP(H),
MedStar Georgetown University Hospital